← Leaderboards
Joel M Friedman
Yeshiva University
$9,068,244
Attributed
$9,496,862
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$31,886,343 · 14
By mechanism
P01$26,494,857 · 6
R01$4,134,030 · 5
R21$456,500 · 1
R56$400,737 · 1
P20$400,219 · 1
Top collaborators
- Rhoda Hirsch2 shared
- Marcos Intaglietta1 shared
Most similar at Yeshiva University
Same institution · by research overlap
- Seetharama A Acharya$4,285,000
- Jack Peisach$2,507,055
- Belur N Manjula$798,578
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyProgramsBaseMedicineHemoglobinReactionProductionNanoparticleBiophysicsIn VivoBlood CapillariesGenerationsPhysiologicalTransfusionPolymerizationRecombinantsPreventStructureHaptoglobinsBinding (Molecular Function)Toxic EffectCapillaryBiochemicalOxygen
Grant awards (43)
Development of a nanotechnology resource center to advance urological research$198,217
P20 · FY2020 · DK · contact PI
Maximizing transfusion efficacy through nitric oxide enhancement strategies$400,737
R56 · FY2019 · HL · contact PI
Development of a nanotechnology resource center to advance urological research$202,002
P20 · FY2019 · DK · contact PI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY$2,136,665
P01 · FY2016 · HL · contact PI
Bioactive NO from Acellular Hbs and Nanoparticles$411,168
P01 · FY2016 · HL · contact PI
Administrative Core$145,881
P01 · FY2016 · HL · contact PI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY$1,929,230
P01 · FY2015 · HL · contact PI
Bioactive NO from Acellular Hbs and Nanoparticles$371,251
P01 · FY2015 · HL · contact PI
Bioactive NO from Acellular Hbs and Nanoparticles$292,057
P01 · FY2015 · HL · contact PI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY$175,385
P01 · FY2015 · HL · contact PI
Administrative Core$133,203
P01 · FY2015 · HL · contact PI
Administrative Core$131,718
P01 · FY2015 · HL · contact PI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY$2,087,525
P01 · FY2014 · HL · contact PI
Bioactive NO from Acellular Hbs and Nanoparticles$290,549
P01 · FY2014 · HL · contact PI
Administrative Core$131,695
P01 · FY2014 · HL · contact PI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY$2,026,581
P01 · FY2013 · HL · contact PI
Bioactive NO from Acellular Hbs and Nanoparticles$391,432
P01 · FY2013 · HL · contact PI
Administrative Core$138,879
P01 · FY2013 · HL · contact PI
MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY$2,274,339
P01 · FY2012 · HL · contact PI
Bioactive NO from Acellular Hbs and Nanoparticles$411,167
P01 · FY2012 · HL · contact PI
Production of Bioactive NO: Origin of Hemoglobin E Associated Pathophysiology$207,500
R21 · FY2012 · HL · contact PI
Administrative Core$145,881
P01 · FY2012 · HL · contact PI
Production of Bioactive NO: Origin of Hemoglobin E Associated Pathophysiology$249,000
R21 · FY2011 · HL · contact PI
Protein Reactivity in Sol-Gel Matrices: Hydration Effects in Confined Spaces$331,998
R01 · FY2010 · GM · contact PI
Protein Reactivity in Sol-Gel Matrices: Hydration Effects in Confined Spaces$324,080
R01 · FY2009 · GM · contact PI
TrHbs: Biophysical Consequences of a Nonpolar Tunnel$361,413
R01 · FY2007 · AI · contact PI
New Paradigms in the Design of Blood Substitutes$2,409,135
P01 · FY2006 · HL · contact PI
Conformation, dynamics and reactivity of enhanced Hb$411,185
P01 · FY2006 · HL · contact PI
TrHbs: Biophysical Consequences of a Nonpolar Tunnel$366,919
R01 · FY2006 · AI · contact PI
New Paradigms in the Design of Blood Substitutes$2,403,493
P01 · FY2005 · HL
TrHbs: Biophysical Consequences of a Nonpolar Tunnel$375,750
R01 · FY2005 · AI
New Paradigms in the Design of Blood Substitutes$2,341,730
P01 · FY2004 · HL
TrHbs: Biophysical Consequences of a Nonpolar Tunnel$375,750
R01 · FY2004 · AI
New Paradigms in the Design of Blood Substitutes$2,281,040
P01 · FY2003 · HL
BIOPHYSICAL EVALUATION OF SOL-GEL ENCAPSULATED PROTEINS$340,219
R01 · FY2003 · EB
New Paradigms in the Design of Blood Substitutes$2,324,358
P01 · FY2002 · HL
Conformation, dynamics and reactivity of enhanced Hb$387,393
P01 · FY2002 · HL
BIOPHYSICAL EVALUATION OF SOL-GEL ENCAPSULATED PROTEINS$332,083
R01 · FY2002 · EB
BIOPHYSICAL EVALUATION OF SOL-GEL ENCAPSULATED PROTEINS$324,507
R01 · FY2001 · HL
STRUCTURE, FUNCTION AND DYNAMICS IN TRANSFERRIN$148,636
P01 · FY2001 · DK
COMMUNICATION PATHWAYS IN CENTRAL CAVITY MODIFIED HBS$667,533
R01 · FY2000 · HL
BIOPHYSICAL EVALUATION OF SOL-GEL ENCAPSULATED PROTEINS$333,778
R01 · FY2000 · HL
STRUCTURE, FUNCTION AND DYNAMICS IN TRANSFERRIN$163,281
P01 · FY2000 · DK